Impact of HIV-1 env Genetic Context on Resistance to Enfuvirtide
Author Information
Author(s): Baatz Franky, Nijhuis Monique, Lemaire Morgane, Riedijk Martiene, Wensing Annemarie M. J., Servais Jean-Yves, van Ham Petra M., Hoepelman Andy I. M., Koopmans Peter P., Sprenger Herman G., Devaux Carole, Schmit Jean-Claude, Perez Bercoff Danielle
Primary Institution: Laboratory of Retrovirology, CRP-Santé, Luxembourg
Hypothesis
The study investigates the role of the HIV-1 env genetic context in resistance to the fusion inhibitor enfuvirtide and its effect on viral infectivity.
Conclusion
The HR1–HR2 region is the main contributor to resistance against enfuvirtide, while the surrounding env genetic context modulates susceptibility and infectivity.
Supporting Evidence
- Resistance mutations to enfuvirtide mainly occur within the HR1 region.
- The env genetic context can influence the level of enfuvirtide resistance.
- X4 viruses showed higher resistance levels compared to R5 viruses.
- Infectivity of full Env recombinant viruses increased under prolonged drug pressure.
Takeaway
This study looks at how changes in the HIV virus can make it resistant to a medicine called enfuvirtide, and how these changes also affect how well the virus can infect cells.
Methodology
The study compared enfuvirtide susceptibility and infectivity of recombinant viral pairs from longitudinal env clones of patients failing enfuvirtide therapy.
Potential Biases
Potential biases may arise from the selection of patients and the specific viral strains studied.
Limitations
The study is limited by the small sample size and the focus on specific patient populations.
Participant Demographics
Five heavily treated male patients infected with subtype B HIV-1.
Statistical Information
P-Value
p<0.05
Confidence Interval
[177;2401]
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website